Botox Mitigates Debilitating Dry Mouth in Prostate Cancer Patients Receiving Radiopharmaceutical The
June 24, 2025
June 24, 2025
RESTON, Virginia, June 24 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:
* * *
Botox Mitigates Debilitating Dry Mouth in Prostate Cancer Patients Receiving Radiopharmaceutical Therapy
*
NEW ORLEANS (June 24,2025) -- A dual-protective approach using botulinum toxin (Botox) alongside an anti-nausea patch significantly reduces salivary gland toxicity in patients with metastatic pros . . .
* * *
Botox Mitigates Debilitating Dry Mouth in Prostate Cancer Patients Receiving Radiopharmaceutical Therapy
*
NEW ORLEANS (June 24,2025) -- A dual-protective approach using botulinum toxin (Botox) alongside an anti-nausea patch significantly reduces salivary gland toxicity in patients with metastatic pros . . .